Nektar Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results

/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter and full year ended December 31, 2021. Cash and...

Related Keywords

Germany ,California ,United States ,Alabama ,Hyderabad ,Andhra Pradesh ,India ,San Francisco ,American ,Dan Budwick ,Howardw Robin ,Vivian Wu ,Eli Lilly ,Bristol Myers Squibb ,Bristol Myers ,Nektar Therapeutics ,Society For Immunotherapy Of Cancer ,Nasdaq ,Exchange Commission ,American Society Of Hematology ,Pfizer ,Oncology Congress ,Merck Kga ,European Society For Medical Oncology Immuno ,Pfizer Inc ,Merck Kgaa ,American Society ,Medical Oncology Immuno ,Clinical Oncology ,Translational Autoimmunity ,Discuss Fourth Quarter ,Quarterly Report ,Health Care Amp Hospitals ,Biotechnology ,Pharmaceuticals ,Medical Pharmaceuticals ,Earnings ,